Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms

Fig. 3

Arsenic trioxide (ATO) promotes the ability of homoharringtonine (HHT) to decrease the proportion of CD34+ CD38 cells. Cells were treated with HHT, ATO, or HHT + ATO for 2 days, and cell surface antigen of Kasumi-1 (a) and KG-1 (c) cells was detected using FACS. The relative expression levels of CD34, CD38, and CD96 mRNA of Kasumi-1 (b) and KG-1 (d) cells were quantified using qPCR. Error bars represent three independent experiments. P < 0.05*, P < 0.01**, P < 0.001***

Back to article page